Cartalax 20mg (Bioregulator) – Research-Based Peptide for Cartilage & Connective Tissue Studies
Cartalax 20mg (Bioregulator) is a research-grade peptide widely studied for its role in cartilage biology, joint health, and connective tissue regulation. Developed within advanced peptide bioregulator research programs, Cartalax is gaining attention for its tissue-specific activity and potential influence on cellular regeneration pathways.
🔬 What Is Cartalax 20mg?
Cartalax is a synthetic short-chain peptide (bioregulator) composed of amino acids such as alanine, glutamate, and aspartate. It is classified as a tissue-targeted peptide, meaning it is designed to act specifically on cartilage and connective tissues.
Unlike general supplements, Cartalax is primarily used in laboratory and preclinical research settings to study mechanisms related to cellular repair, aging, and tissue maintenance.
⚙️ Mechanism of Action (Research Insights)
Scientific research suggests that Cartalax may function by:
- 🧬 Modulating gene expression in cartilage cells (chondrocytes)
- 🔄 Supporting protein synthesis and extracellular matrix production
- đź§Ş Influencing cellular signaling pathways involved in tissue repair
- 🛡️ Promoting cell survival and reducing apoptosis (cell damage)
These mechanisms distinguish Cartalax from traditional approaches that only address symptoms rather than underlying cellular processes.
📊 Key Research Findings on Cartalax
🦴 Cartilage Integrity & Regeneration
Preclinical studies show that peptides like Cartalax may help:
- Improve cartilage structure
- Slow degeneration in joint models
- Support extracellular matrix stability
đź§« Cellular Activity & Proliferation
Research indicates Cartalax may:
- Increase fibroblast and chondrocyte activity
- Enhance markers of cell growth (e.g., Ki-67)
- Support tissue regeneration processes
đź§Ş Connective Tissue & Aging Research
Cartalax is being explore for its potential role in:
- Age-related cartilage decline
- Osteoarthritis research models
- Connective tissue repair and maintenance
🧬 Why Researchers Are Interested in Cartalax
Cartilage has limited natural regenerative capacity, making it a key focus in regenerative medicine. Cartalax offers a unique approach by targeting:
- Cellular signaling pathways instead of symptoms
- Gene-level regulation in cartilage tissue
- Precision bioregulation for musculoskeletal research
This makes it a valuable tool in studies related to joint health, longevity, and tissue engineering.
📦 Product Specifications
- Product Name: Cartalax 20mg
- Type: Synthetic peptide bioregulator
- Form: Lyophilized powder (research use)
- Concentration: 20mg per vial
- Research Focus: Cartilage biology, connective tissue signaling, cellular regeneration
👨‍🔬 Intended Use (Research Context Only)
Cartalax 20mg is design for:
- Laboratory research
- In vitro and in vivo studies
- Scientific investigation into cartilage and connective tissue
⚠️ Not intended for human consumption or clinical use



Reviews
There are no reviews yet.